世界のCDKL5欠乏症（CDD）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global CDKL5 Deficiency Disorder (CDD) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3983
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、89ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、CDKL5欠乏症（CDD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（従来型医薬品、新型医薬品）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・CDKL5欠乏症（CDD）の市場動向
・企業の競争状況、市場シェア
・CDKL5欠乏症（CDD）の種類別市場規模と予測2016-2027（従来型医薬品、新型医薬品）
・CDKL5欠乏症（CDD）の用途別市場規模と予測2016-2027（病院、診療所、その他）
・CDKL5欠乏症（CDD）の北米市場規模2016-2027（アメリカ、カナダ）
・CDKL5欠乏症（CDD）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・CDKL5欠乏症（CDD）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・CDKL5欠乏症（CDD）の中南米市場規模2016-2027（メキシコ、ブラジル）
・CDKL5欠乏症（CDD）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Marinus Pharmaceuticals、Ovid Therapeutics/Takeda、Zogenix、PTC Therapeutics）
・結論

CDKL5 deficiency disorder (CDD) is a rare developmental epileptic encephalopathy (DEE), X-linked genetic condition which results in early-onset, difficult to control seizures and severe neuro-developmental impairment. CDKL5 stands for cyclin-dependent kinase-like 5 and mutations in this gene were first identified as disease-causing in 2004. CDD was previously not considered as a separate indication; rather, it was assumed to be an atypical form of Rett Syndrome. The CDKL5 gene provides instructions for making proteins that are essential for normal brain and neuron development. The condition was previously known as serine/threonine-protein kinase 9 (STK9), and it has been classified as DEE because the genetic change causes epileptic activity as well as severe impairment of the development. The CDKL5 gene is located on the X chromosome. The X chromosome is one of the sex chromosomes; females have two X’s, and males have one X and one Y chromosome. Although many identified patients are males, because of the location of the gene, this disorder mainly affects females. Affected males may have more severe symptoms than females.

Market Analysis and Insights: Global CDKL5 Deficiency Disorder (CDD) Market
The global CDKL5 Deficiency Disorder (CDD) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CDKL5 Deficiency Disorder (CDD) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CDKL5 Deficiency Disorder (CDD) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CDKL5 Deficiency Disorder (CDD) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CDKL5 Deficiency Disorder (CDD) market.

Global CDKL5 Deficiency Disorder (CDD) Scope and Market Size
CDKL5 Deficiency Disorder (CDD) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CDKL5 Deficiency Disorder (CDD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Traditional Drugs
Emerging Drugs

Segment by Application
Hospital
Clinic
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Marinus Pharmaceuticals
Ovid Therapeutics/Takeda
Zogenix
PTC Therapeutics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CDKL5 Deficiency Disorder (CDD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Traditional Drugs
1.2.3 Emerging Drugs
1.3 Market by Application
1.3.1 Global CDKL5 Deficiency Disorder (CDD) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global CDKL5 Deficiency Disorder (CDD) Market Perspective (2016-2027)
2.2 CDKL5 Deficiency Disorder (CDD) Growth Trends by Regions
2.2.1 CDKL5 Deficiency Disorder (CDD) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 CDKL5 Deficiency Disorder (CDD) Historic Market Share by Regions (2016-2021)
2.2.3 CDKL5 Deficiency Disorder (CDD) Forecasted Market Size by Regions (2022-2027)
2.3 CDKL5 Deficiency Disorder (CDD) Industry Dynamic
2.3.1 CDKL5 Deficiency Disorder (CDD) Market Trends
2.3.2 CDKL5 Deficiency Disorder (CDD) Market Drivers
2.3.3 CDKL5 Deficiency Disorder (CDD) Market Challenges
2.3.4 CDKL5 Deficiency Disorder (CDD) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top CDKL5 Deficiency Disorder (CDD) Players by Revenue
3.1.1 Global Top CDKL5 Deficiency Disorder (CDD) Players by Revenue (2016-2021)
3.1.2 Global CDKL5 Deficiency Disorder (CDD) Revenue Market Share by Players (2016-2021)
3.2 Global CDKL5 Deficiency Disorder (CDD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CDKL5 Deficiency Disorder (CDD) Revenue
3.4 Global CDKL5 Deficiency Disorder (CDD) Market Concentration Ratio
3.4.1 Global CDKL5 Deficiency Disorder (CDD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CDKL5 Deficiency Disorder (CDD) Revenue in 2020
3.5 CDKL5 Deficiency Disorder (CDD) Key Players Head office and Area Served
3.6 Key Players CDKL5 Deficiency Disorder (CDD) Product Solution and Service
3.7 Date of Enter into CDKL5 Deficiency Disorder (CDD) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 CDKL5 Deficiency Disorder (CDD) Breakdown Data by Type
4.1 Global CDKL5 Deficiency Disorder (CDD) Historic Market Size by Type (2016-2021)
4.2 Global CDKL5 Deficiency Disorder (CDD) Forecasted Market Size by Type (2022-2027)

5 CDKL5 Deficiency Disorder (CDD) Breakdown Data by Application
5.1 Global CDKL5 Deficiency Disorder (CDD) Historic Market Size by Application (2016-2021)
5.2 Global CDKL5 Deficiency Disorder (CDD) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America CDKL5 Deficiency Disorder (CDD) Market Size (2016-2027)
6.2 North America CDKL5 Deficiency Disorder (CDD) Market Size by Type
6.2.1 North America CDKL5 Deficiency Disorder (CDD) Market Size by Type (2016-2021)
6.2.2 North America CDKL5 Deficiency Disorder (CDD) Market Size by Type (2022-2027)
6.2.3 North America CDKL5 Deficiency Disorder (CDD) Market Size by Type (2016-2027)
6.3 North America CDKL5 Deficiency Disorder (CDD) Market Size by Application
6.3.1 North America CDKL5 Deficiency Disorder (CDD) Market Size by Application (2016-2021)
6.3.2 North America CDKL5 Deficiency Disorder (CDD) Market Size by Application (2022-2027)
6.3.3 North America CDKL5 Deficiency Disorder (CDD) Market Size by Application (2016-2027)
6.4 North America CDKL5 Deficiency Disorder (CDD) Market Size by Country
6.4.1 North America CDKL5 Deficiency Disorder (CDD) Market Size by Country (2016-2021)
6.4.2 North America CDKL5 Deficiency Disorder (CDD) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe CDKL5 Deficiency Disorder (CDD) Market Size (2016-2027)
7.2 Europe CDKL5 Deficiency Disorder (CDD) Market Size by Type
7.2.1 Europe CDKL5 Deficiency Disorder (CDD) Market Size by Type (2016-2021)
7.2.2 Europe CDKL5 Deficiency Disorder (CDD) Market Size by Type (2022-2027)
7.2.3 Europe CDKL5 Deficiency Disorder (CDD) Market Size by Type (2016-2027)
7.3 Europe CDKL5 Deficiency Disorder (CDD) Market Size by Application
7.3.1 Europe CDKL5 Deficiency Disorder (CDD) Market Size by Application (2016-2021)
7.3.2 Europe CDKL5 Deficiency Disorder (CDD) Market Size by Application (2022-2027)
7.3.3 Europe CDKL5 Deficiency Disorder (CDD) Market Size by Application (2016-2027)
7.4 Europe CDKL5 Deficiency Disorder (CDD) Market Size by Country
7.4.1 Europe CDKL5 Deficiency Disorder (CDD) Market Size by Country (2016-2021)
7.4.2 Europe CDKL5 Deficiency Disorder (CDD) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Size (2016-2027)
8.2 Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Size by Type
8.2.1 Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Size by Type (2016-2027)
8.3 Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Size by Application
8.3.1 Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Size by Application (2016-2027)
8.4 Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Size by Region
8.4.1 Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America CDKL5 Deficiency Disorder (CDD) Market Size (2016-2027)
9.2 Latin America CDKL5 Deficiency Disorder (CDD) Market Size by Type
9.2.1 Latin America CDKL5 Deficiency Disorder (CDD) Market Size by Type (2016-2021)
9.2.2 Latin America CDKL5 Deficiency Disorder (CDD) Market Size by Type (2022-2027)
9.2.3 Latin America CDKL5 Deficiency Disorder (CDD) Market Size by Type (2016-2027)
9.3 Latin America CDKL5 Deficiency Disorder (CDD) Market Size by Application
9.3.1 Latin America CDKL5 Deficiency Disorder (CDD) Market Size by Application (2016-2021)
9.3.2 Latin America CDKL5 Deficiency Disorder (CDD) Market Size by Application (2022-2027)
9.3.3 Latin America CDKL5 Deficiency Disorder (CDD) Market Size by Application (2016-2027)
9.4 Latin America CDKL5 Deficiency Disorder (CDD) Market Size by Country
9.4.1 Latin America CDKL5 Deficiency Disorder (CDD) Market Size by Country (2016-2021)
9.4.2 Latin America CDKL5 Deficiency Disorder (CDD) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Size (2016-2027)
10.2 Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Size by Type
10.2.1 Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Size by Type (2016-2027)
10.3 Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Size by Application
10.3.1 Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Size by Application (2016-2027)
10.4 Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Size by Country
10.4.1 Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Marinus Pharmaceuticals
11.1.1 Marinus Pharmaceuticals Company Details
11.1.2 Marinus Pharmaceuticals Business Overview
11.1.3 Marinus Pharmaceuticals CDKL5 Deficiency Disorder (CDD) Introduction
11.1.4 Marinus Pharmaceuticals Revenue in CDKL5 Deficiency Disorder (CDD) Business (2016-2021)
11.1.5 Marinus Pharmaceuticals Recent Development
11.2 Ovid Therapeutics/Takeda
11.2.1 Ovid Therapeutics/Takeda Company Details
11.2.2 Ovid Therapeutics/Takeda Business Overview
11.2.3 Ovid Therapeutics/Takeda CDKL5 Deficiency Disorder (CDD) Introduction
11.2.4 Ovid Therapeutics/Takeda Revenue in CDKL5 Deficiency Disorder (CDD) Business (2016-2021)
11.2.5 Ovid Therapeutics/Takeda Recent Development
11.3 Zogenix
11.3.1 Zogenix Company Details
11.3.2 Zogenix Business Overview
11.3.3 Zogenix CDKL5 Deficiency Disorder (CDD) Introduction
11.3.4 Zogenix Revenue in CDKL5 Deficiency Disorder (CDD) Business (2016-2021)
11.3.5 Zogenix Recent Development
11.4 PTC Therapeutics
11.4.1 PTC Therapeutics Company Details
11.4.2 PTC Therapeutics Business Overview
11.4.3 PTC Therapeutics CDKL5 Deficiency Disorder (CDD) Introduction
11.4.4 PTC Therapeutics Revenue in CDKL5 Deficiency Disorder (CDD) Business (2016-2021)
11.4.5 PTC Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global CDKL5 Deficiency Disorder (CDD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Traditional Drugs
Table 3. Key Players of Emerging Drugs
Table 4. Global CDKL5 Deficiency Disorder (CDD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global CDKL5 Deficiency Disorder (CDD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global CDKL5 Deficiency Disorder (CDD) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global CDKL5 Deficiency Disorder (CDD) Market Share by Regions (2016-2021)
Table 8. Global CDKL5 Deficiency Disorder (CDD) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global CDKL5 Deficiency Disorder (CDD) Market Share by Regions (2022-2027)
Table 10. CDKL5 Deficiency Disorder (CDD) Market Trends
Table 11. CDKL5 Deficiency Disorder (CDD) Market Drivers
Table 12. CDKL5 Deficiency Disorder (CDD) Market Challenges
Table 13. CDKL5 Deficiency Disorder (CDD) Market Restraints
Table 14. Global CDKL5 Deficiency Disorder (CDD) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global CDKL5 Deficiency Disorder (CDD) Market Share by Players (2016-2021)
Table 16. Global Top CDKL5 Deficiency Disorder (CDD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CDKL5 Deficiency Disorder (CDD) as of 2020)
Table 17. Ranking of Global Top CDKL5 Deficiency Disorder (CDD) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by CDKL5 Deficiency Disorder (CDD) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players CDKL5 Deficiency Disorder (CDD) Product Solution and Service
Table 21. Date of Enter into CDKL5 Deficiency Disorder (CDD) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CDKL5 Deficiency Disorder (CDD) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global CDKL5 Deficiency Disorder (CDD) Revenue Market Share by Type (2016-2021)
Table 25. Global CDKL5 Deficiency Disorder (CDD) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global CDKL5 Deficiency Disorder (CDD) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global CDKL5 Deficiency Disorder (CDD) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global CDKL5 Deficiency Disorder (CDD) Revenue Market Share by Application (2016-2021)
Table 29. Global CDKL5 Deficiency Disorder (CDD) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global CDKL5 Deficiency Disorder (CDD) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America CDKL5 Deficiency Disorder (CDD) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America CDKL5 Deficiency Disorder (CDD) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America CDKL5 Deficiency Disorder (CDD) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America CDKL5 Deficiency Disorder (CDD) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America CDKL5 Deficiency Disorder (CDD) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America CDKL5 Deficiency Disorder (CDD) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe CDKL5 Deficiency Disorder (CDD) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe CDKL5 Deficiency Disorder (CDD) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe CDKL5 Deficiency Disorder (CDD) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe CDKL5 Deficiency Disorder (CDD) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe CDKL5 Deficiency Disorder (CDD) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe CDKL5 Deficiency Disorder (CDD) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America CDKL5 Deficiency Disorder (CDD) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America CDKL5 Deficiency Disorder (CDD) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America CDKL5 Deficiency Disorder (CDD) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America CDKL5 Deficiency Disorder (CDD) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America CDKL5 Deficiency Disorder (CDD) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America CDKL5 Deficiency Disorder (CDD) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Marinus Pharmaceuticals Company Details
Table 62. Marinus Pharmaceuticals Business Overview
Table 63. Marinus Pharmaceuticals CDKL5 Deficiency Disorder (CDD) Product
Table 64. Marinus Pharmaceuticals Revenue in CDKL5 Deficiency Disorder (CDD) Business (2016-2021) & (US$ Million)
Table 65. Marinus Pharmaceuticals Recent Development
Table 66. Ovid Therapeutics/Takeda Company Details
Table 67. Ovid Therapeutics/Takeda Business Overview
Table 68. Ovid Therapeutics/Takeda CDKL5 Deficiency Disorder (CDD) Product
Table 69. Ovid Therapeutics/Takeda Revenue in CDKL5 Deficiency Disorder (CDD) Business (2016-2021) & (US$ Million)
Table 70. Ovid Therapeutics/Takeda Recent Development
Table 71. Zogenix Company Details
Table 72. Zogenix Business Overview
Table 73. Zogenix CDKL5 Deficiency Disorder (CDD) Product
Table 74. Zogenix Revenue in CDKL5 Deficiency Disorder (CDD) Business (2016-2021) & (US$ Million)
Table 75. Zogenix Recent Development
Table 76. PTC Therapeutics Company Details
Table 77. PTC Therapeutics Business Overview
Table 78. PTC Therapeutics CDKL5 Deficiency Disorder (CDD) Product
Table 79. PTC Therapeutics Revenue in CDKL5 Deficiency Disorder (CDD) Business (2016-2021) & (US$ Million)
Table 80. PTC Therapeutics Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CDKL5 Deficiency Disorder (CDD) Market Share by Type: 2020 VS 2027
Figure 2. Traditional Drugs Features
Figure 3. Emerging Drugs Features
Figure 4. Global CDKL5 Deficiency Disorder (CDD) Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. CDKL5 Deficiency Disorder (CDD) Report Years Considered
Figure 9. Global CDKL5 Deficiency Disorder (CDD) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global CDKL5 Deficiency Disorder (CDD) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global CDKL5 Deficiency Disorder (CDD) Market Share by Regions: 2020 VS 2027
Figure 12. Global CDKL5 Deficiency Disorder (CDD) Market Share by Regions (2022-2027)
Figure 13. Global CDKL5 Deficiency Disorder (CDD) Market Share by Players in 2020
Figure 14. Global Top CDKL5 Deficiency Disorder (CDD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CDKL5 Deficiency Disorder (CDD) as of 2020
Figure 15. The Top 10 and 5 Players Market Share by CDKL5 Deficiency Disorder (CDD) Revenue in 2020
Figure 16. Global CDKL5 Deficiency Disorder (CDD) Revenue Market Share by Type (2016-2021)
Figure 17. Global CDKL5 Deficiency Disorder (CDD) Revenue Market Share by Type (2022-2027)
Figure 18. North America CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America CDKL5 Deficiency Disorder (CDD) Market Share by Type (2016-2027)
Figure 20. North America CDKL5 Deficiency Disorder (CDD) Market Share by Application (2016-2027)
Figure 21. North America CDKL5 Deficiency Disorder (CDD) Market Share by Country (2016-2027)
Figure 22. United States CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe CDKL5 Deficiency Disorder (CDD) Market Share by Type (2016-2027)
Figure 26. Europe CDKL5 Deficiency Disorder (CDD) Market Share by Application (2016-2027)
Figure 27. Europe CDKL5 Deficiency Disorder (CDD) Market Share by Country (2016-2027)
Figure 28. Germany CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Share by Type (2016-2027)
Figure 36. Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Share by Application (2016-2027)
Figure 37. Asia-Pacific CDKL5 Deficiency Disorder (CDD) Market Share by Region (2016-2027)
Figure 38. China CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America CDKL5 Deficiency Disorder (CDD) Market Share by Type (2016-2027)
Figure 46. Latin America CDKL5 Deficiency Disorder (CDD) Market Share by Application (2016-2027)
Figure 47. Latin America CDKL5 Deficiency Disorder (CDD) Market Share by Country (2016-2027)
Figure 48. Mexico CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Share by Type (2016-2027)
Figure 52. Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Share by Application (2016-2027)
Figure 53. Middle East & Africa CDKL5 Deficiency Disorder (CDD) Market Share by Country (2016-2027)
Figure 54. Turkey CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE CDKL5 Deficiency Disorder (CDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Marinus Pharmaceuticals Revenue Growth Rate in CDKL5 Deficiency Disorder (CDD) Business (2016-2021)
Figure 58. Ovid Therapeutics/Takeda Revenue Growth Rate in CDKL5 Deficiency Disorder (CDD) Business (2016-2021)
Figure 59. Zogenix Revenue Growth Rate in CDKL5 Deficiency Disorder (CDD) Business (2016-2021)
Figure 60. PTC Therapeutics Revenue Growth Rate in CDKL5 Deficiency Disorder (CDD) Business (2016-2021)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Global Premenstrual Dysphoric Disorder (PMDD) Market Size, Status and Forecast 2021-2027
QFJ1-4754 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、月経前不快気分障害（PMDD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、注入剤、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の視神経スペクトラム障害（NMOSD）市場規模・現状・予測（2021年-2027年）

Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, Status and Forecast 2021-2027
QFJ1-4571 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、視神経スペクトラム障害（NMOSD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（静脈注射、経口、皮下、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界のアルギナーゼ欠損症治療薬市場規模・現状・予測（2021年-2027年）

Global Arginase Deficiency Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3850 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、アルギナーゼ欠損症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界のアルギナーゼ欠損症治療市場規模・現状・予測（2021年-2027年）

Global Arginase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3851 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、アルギナーゼ欠損症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

世界のα1アンチトリプシン欠乏症増強療法市場規模・現状・予測（2021年-2027年）

Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3783 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、α1アンチトリプシン欠乏症増強療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（グラシア、アララストNP、プロラスチンC、その他）、用途別市場規模（病院、専門診療所）、主要地域別市場規模（北米、アメ...

世界のACTH欠乏症治療市場規模・現状・予測（2021年-2027年）

Global ACTH Deficiency Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3753 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ACTH欠乏症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（先天性、後天性）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界のオルニチン-トランスカルバミラーゼ欠損症市場規模・現状・予測（2021年-2027年）

Global Ornithine-Transcarbamylase Deficiency Market Size, Status and Forecast 2021-2027
QFJ1-4629 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、オルニチン-トランスカルバミラーゼ欠損症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（DTX-301、SEL-313、SHP-641、PRX-OTC、その他）、用途別市場規模（病院、クリニック、その...

世界のビオチニダーゼ欠損症市場規模・現状・予測（2021年-2027年）

Global Biotinidase Deficiency Market Size, Status and Forecast 2021-2027
QFJ1-5622 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、ビオチニダーゼ欠損症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（重度ビオチニダーゼ欠損症、部分的ビオチニダーゼ欠損症）、用途別市場規模（病院、専門クリニック、ドラッグストア、小売薬局、オンライン薬...

世界の亜鉛欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Zinc Deficiency Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5049 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、亜鉛欠乏症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口剤、注射剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界のHPV関連疾患市場規模・現状・予測（2021年-2027年）

Global HPV Associated Disorder Market Size, Status and Forecast 2021-2027
QFJ1-4327 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、HPV関連疾患の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（予防、治療）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

世界の強迫性障害治療薬市場規模・現状・予測（2021年-2027年） Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions"). The launch of new molecules is one of the primary drivers for the obsessive-compulsive di…
世界のアルギナーゼ欠損症治療市場規模・現状・予測（2021年-2027年） Argininemia, also called arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood. Market Analysis and Insights: Global Arginase Deficiency Treatment Market The global Arginase Deficiency Treatme…
世界のアルギナーゼ欠損症治療薬市場規模・現状・予測（2021年-2027年） Argininemia, also called arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood. Market Analysis and Insights: Global Arginase Deficiency Therapeutics Market The global Arginase Deficiency Ther…
強迫性障害治療薬のグローバル市場：規模・現状・予測2019-2025 Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").The launch of new molecules is one of the primary drivers for the obsessive-compulsive dis…
強迫性障害治療薬のグローバル市場：規模・現状・予測2019-2025 Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").The launch of new molecules is one of the primary drivers for the obsessive-compulsive dis…